| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | Chief Commercial Officer, MRD | Common Stock | 347,238 | $2,423,721 | $6.98 | 05 Mar 2025 | Direct |
| Adaptive Biotechnologies Corp | Chief Commercial Officer, MRD | Stock Option (right to buy) | 180,029 | 04 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 04 Mar 2025 | 3 | -$181,641 | 4 | Chief Commercial Officer, MRD | 06 Mar 2025, 19:22 |
| ADPT | Adaptive Biotechnologies Corp | 08 Oct 2024 | 2 | +$9,900 | 4 | Chief Commercial Officer, MRD | 10 Oct 2024, 17:47 |
| ADPT | Adaptive Biotechnologies Corp | 04 Mar 2024 | 4 | -$44,629 | 4 | Chief Commercial Officer, MRD | 06 Mar 2024, 19:39 |
| ADPT | Adaptive Biotechnologies Corp | 25 Jan 2024 | 0 | $0 | 3 | Chief Commercial Officer, MRD | 06 Mar 2024, 19:38 |